-
sodium 7-[(1R,2R,3R,5S)-2-[(3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl]hept-5-enoate hydrate
-
ChemBase ID:
154278
-
Molecular Formular:
C22H30ClNaO7
-
Molecular Mass:
464.91217
-
Monoisotopic Mass:
464.15777526
-
SMILES and InChIs
SMILES:
c1cc(cc(c1)Cl)OC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C/CCCC(=O)[O-])O)O)O.O.[Na+]
Canonical SMILES:
[O-]C(=O)CCC/C=C/C[C@H]1[C@@H](O)C[C@H]([C@@H]1C=C[C@H](COc1cccc(c1)Cl)O)O.O.[Na+]
InChI:
InChI=1S/C22H29ClO6.Na.H2O/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28;;/h1,3,5-7,10-12,16,18-21,24-26H,2,4,8-9,13-14H2,(H,27,28);;1H2/q;+1;/p-1/t16-,18-,19-,20+,21-;;/m1../s1
InChIKey:
ZEQHRVULQBYULU-BRFXSNOJSA-M
-
Cite this record
CBID:154278 http://www.chembase.cn/molecule-154278.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
sodium 7-[(1R,2R,3R,5S)-2-[(3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl]hept-5-enoate hydrate
|
|
|
IUPAC Traditional name
|
sodium 7-[(1R,2R,3R,5S)-2-[(3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl]hept-5-enoate hydrate
|
|
|
Synonyms
|
(+/-)-16-(3-Chlorophenoxy)-9,11,15R-trihydroxy-17,18,19,20-tetranorprosta-5Z,13E-dien-1-oic acid sodium salt hydrate
|
(+/-)-Cloprostenol sodium salt hydrate
|
|
|
CAS Number
|
|
EC Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
4.3552938
|
H Acceptors
|
6
|
H Donor
|
3
|
LogD (pH = 5.5)
|
1.4731349
|
LogD (pH = 7.4)
|
-0.2759445
|
Log P
|
2.6461124
|
Molar Refractivity
|
123.5892 cm3
|
Polarizability
|
43.43382 Å3
|
Polar Surface Area
|
110.05 Å2
|
Rotatable Bonds
|
11
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
C6116
|
Biochem/physiol Actions Cloprostenol is a potent FP prostanoid receptor agonist. It is 2- to 3-fold more potent than fluprostenol but less selective. Cloprostenol is similar in potency to PGF2α at EP and TP prostanoid receptors. It is used for the treatment of infertility in sows and gilts. |
PATENTS
PATENTS
PubChem Patent
Google Patent